Literature DB >> 6638754

Antimicrobial susceptibility of Bifidobacterium.

D Matteuzzi, F Crociani, P Brigidi.   

Abstract

The susceptibility pattern of 459 strains of bifidobacteria, representing 15 species, to 16 antimicrobial agents was determined by the broth dilution method. The majority of the strains derived from human faeces. Penicillin G, erythromycin, clindamycin, vancomycin and bacitracin were the most active compounds; they inhibited 90% of the strains at less than 1.6 micrograms/ml. All strains were susceptible to chloramphenicol (MIC90 = 2.0-5.8 micrograms/ml) and also to lincomycin (MIC50 = 0.64-1.5 micrograms/ml). Neomycin, streptomycin and tetracycline presented a great variability in their activity. Most strains were resistant to polymyxin B, nalidixic acid, kanamycin, gentamicin and metronidazole. The only variation in susceptibility which was observed among the different species concerned Bifidobacterium suis, which generally appeared to be more resistant than other species.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6638754

Source DB:  PubMed          Journal:  Ann Microbiol (Paris)        ISSN: 0300-5410


  3 in total

1.  Evaluation of new broth media for microdilution antibiotic susceptibility testing of Lactobacilli, Pediococci, Lactococci, and Bifidobacteria.

Authors:  Ingo Klare; Carola Konstabel; Sibylle Müller-Bertling; Rolf Reissbrodt; Geert Huys; Marc Vancanneyt; Jean Swings; Herman Goossens; Wolfgang Witte
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

2.  Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from the human gastrointestinal tract.

Authors:  Susana Delgado; Ana Belén Flórez; Baltasar Mayo
Journal:  Curr Microbiol       Date:  2005-03-15       Impact factor: 2.188

3.  Susceptibility of bifidobacteria of animal origin to selected antimicrobial agents.

Authors:  Sigrid Mayrhofer; Christiane Mair; Wolfgang Kneifel; Konrad J Domig
Journal:  Chemother Res Pract       Date:  2011-04-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.